OX40 immunotherapy is a new agent that shows tremendous promise in advanced cancer treatment. It is considered an immune co-stimulator or T cell co-stimulation. Essentially, it stimulates the immune system to fight tumors and cancer cells in the body.
When immunotherapy is combined with other cancer treatments, such as chemotherapy, patients are more likely to experience better outcomes. However, no two agents work the same for every patient, so it is essential to discuss with your oncologist if OX40 or another agent is the best option for your treatment.
Click the link below to find out more: